Creating a library of quality improvement tools for lung diseases
Official title: Developing an "Out of the Box" Quality Improvement Library for Lung Diseases
Funded at Phrase Health, INC. · NIH-10820664 · Data updated 2026-11-12
This study is creating easy-to-use tools for doctors and healthcare workers to help them make better decisions when treating patients with lung diseases, so they can provide even better care.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Phrase Health, INC. NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 17, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $477,191 |
| NIH project number | 1R44HL172570-01 |
| Project ID | NIH-10820664 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients under 12 years of age suffering from chronic lung diseases such as asthma or chronic obstructive pulmonary disease (COPD).
✕Less likely to help
Patients with acute lung conditions or those over the age of 12 may not receive direct benefits from this research.
What this research studies
This research aims to develop a library of quality improvement (QI) templates specifically designed for lung diseases, which will help healthcare providers enhance their clinical decision-making processes. By utilizing a self-service guided walkthrough, healthcare advocates can evaluate the effectiveness of clinical decision support (CDS) systems and implement data-driven improvements in patient care. The project focuses on making these tools accessible and user-friendly, addressing the needs of various healthcare professionals to improve outcomes for patients with lung conditions. The templates will be based on existing successful QI projects and tailored for specific lung diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved clinical outcomes for patients with lung diseases through better implementation of evidence-based practices.
How similar studies have gone: Previous research has shown that clinical decision support systems can significantly improve outcomes in various diseases, indicating a promising potential for this approach in lung disease management.
Where this research is happening
-
Phrase Health, INC.
Philadelphia, United States Active
Researchers
- Principal investigator: Tobias, Marc — Phrase Health, INC.
- Study coordinator: Tobias, Marc
Related research
Other NIH-funded projects on the same topics.
-
Clinical readiness for rare lung diseases (RLDC)
A group at the University of Cincinnati is building a program to speed up care for people with rare lung diseases by tracking patients over time, improving tests and treatments, and sharing information with patients and clinicians.
-
Epithelial cells trigger fibroblast activation in lung fibrosis through CTHRC1-TGFb signaling
A clinician-scientist at Duke is studying how lung lining cells may turn normal fibroblasts into fibrosis-causing cells, aiming to uncover new targets for treatment of diseases like BO and IPF.
-
Molecular origins of chronic lung diseases in the human lung
Researchers are mapping the tiny cell neighborhoods in diseased lungs to find early clues that could protect or restore normal lung function.
-
How lung cells and their surroundings drive fibrosis in interstitial lung diseases
A study to understand how airway cells, surrounding tissue, and their environment contribute to progressive scarring in interstitial lung diseases.
-
Loss of Cilia Maintenance in Acquired and Genetic Lung Diseases
Researchers are studying why tiny hair-like structures in the lungs lose their maintenance and how this affects people with asthma, COPD, and related airway diseases.
-
CMKLR1-targeted imaging to map lung inflammation in ALI and fibrotic lung diseases
A study to test a new PET imaging tool that targets CMKLR1 to visualize lung inflammation and help predict and monitor disease progression in patients with acute lung injury and fibrotic lung diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.